-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Sotera Health, Lowers Price Target to $20

Benzinga·11/04/2026 18:56:37
Listen to the news
Barclays analyst Luke Sergott maintains Sotera Health (NASDAQ:SHC) with a Overweight and lowers the price target from $22 to $20.